Steel Partners, already a significant InMode shareholder, has made an unsolicited $16.75-per-share cash offer to acquire the RF microneedling and energy-device manufacturer, topping a competing CEO-led buyout proposal. The move signals aggressive consolidation in the aesthetic-device space and raises questions about InMode's strategic direction and product roadmap under new ownership.
Steel Partners Bids $16.75/Share for InMode — What a Contested Takeover Means for Device Buyers
Unsolicited offer challenges CEO-led buyout; device consolidation accelerates.

Steel Partners' $16.75-per-share bid tops the CEO-led offer, signaling a contested acquisition.
For practice owners, the immediate concern is continuity: device pricing, rebate structures, training support, and warranty terms often shift during ownership transitions. Steel Partners is a diversified industrial investor with no prior aesthetic-device operating experience, which could mean either hands-off stewardship or significant operational restructuring. The outcome of this bid battle will likely reshape InMode's go-to-market strategy and the economics of RF platforms for independent practices.
Source: original report ↗
Frequently asked questions
What happens to InMode device pricing if Steel Partners wins the takeover?
Pricing typically shifts during ownership transitions as new operators reassess margins and market positioning. Steel Partners' lack of prior aesthetic-device experience means they may either maintain current pricing or restructure rebate and warranty terms to improve profitability—practice owners should lock in pricing agreements now if possible.
Will InMode RF microneedling devices still be supported after a Steel Partners acquisition?
Support continuity is uncertain under new ownership. Steel Partners is a diversified industrial investor without aesthetic-device operating experience, so training, warranty, and technical support structures could remain stable or undergo significant restructuring depending on their operational strategy.
Should I buy an InMode device now before the takeover closes?
If you're considering purchase, now is a strategic time to negotiate—uncertainty often creates leverage for buyers seeking locked-in pricing, extended warranties, or favorable rebate terms. Contact your InMode rep to discuss transition protections before ownership changes hands.
What is Steel Partners' track record with medical device companies?
Steel Partners is a diversified industrial investor with no prior operating experience in aesthetic or medical devices, making this acquisition a new category for them. Their hands-off or restructuring approach will likely depend on InMode's profitability and market position post-acquisition.
How long will the InMode takeover battle take to resolve?
The article does not specify a timeline, but contested takeovers typically take 3-6 months to resolve through shareholder votes and regulatory approval. Practice owners should monitor official InMode communications for updates on the bid process and expected closing date.
What other aesthetic device companies might be affected by InMode consolidation?
The article indicates device consolidation is accelerating across the aesthetic space, though specific competitors are not named. This suggests RF and energy-device manufacturers may face similar acquisition pressure, potentially affecting pricing and availability across the market.
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Seasoned Expat Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.